Tuberculosis in pregnancy and the puerperium

Thorax

Volumn 56, Issue 6, 2001, Pages 494-499

  Ormerod, P ^a  

^a ROYAL BLACKBURN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

BREAST FEEDING; DRUG BLOOD LEVEL; DRUG MILK LEVEL; DRUG SAFETY; FEMALE; FETOTOXICITY; HUMAN; INCIDENCE; NONHUMAN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK FACTOR; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; BREAST FEEDING; FEMALE; HUMANS; INFANT, NEWBORN; INFECTION CONTROL; MATERNAL MORTALITY; MIDDLE AGED; OBSTETRIC LABOR COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PUERPERAL DISORDERS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 0034995825     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.6.494     Document Type: Review

References (95)

1. National survey of notifications of tuberculosis in England and Wales in 1988
2. Tuberculosis in England and Wales in 1993: Results of a national survey
3. Tuberculosis at the end of the 20th century in England and Wales: Results of a national survey in 1998
4. Tuberculosis morbidity in the United States: Final data 1990
5. The third epidemic: Multi drug resistant tuberculosis
6. The pattern of tuberculosis in Queen Elizabeth Central Hospital, Blantyre, Malawi: 1986-1995
7. Genital tuberculosis: A major pelvic factor causing infertility
8. Pregnancy and tuberculosis
9. Tuberculosis and pregnancy
10. Treatment of tuberculosis during pregnancy
11. Tuberculosis and pregnancy
12. Management of pulmonary tuberculosis during pregnancy
13. Pregnancy and pulmonary tuberculosis
14. The effect of pregnancy on the risk of developing active tuberculosis
15. Tuberculosis in association with pregnancy
16. Tuberculosis and pregnancy: A provincial study (1990-96)
17. Tuberculosis and pregnancy
18. Tuberculosis during pregnancy. The Rhode Island experience, 1987-1991
19. Tuberculosis complicated by pregnancy
20. Initial therapy for tuberculosis in the era of multiple drug resistance recommendations of the Advisory Committee on the Elimination of Tuberculosis
21. Treatment of tuberculosis and tuberculosis infection in adults and children
22. Diagnosis and management of tuberculosis during pregnancy
23. Anergy skin testing and tuberculosis preventive therapy for HIV infected persons: Revised recommendations
24. Isoniazid hepatitis among pregnant and postpartum Hispanic patients
25. Isoniazid-associated hepatitis deaths: A review of available information
26. Tuberculin sensitivity in pregnancy
27. Cutaneous anergy in pregnant and nonpregnant women with human immunodeficiency virus
28. Mycobacterium tuberculosis infection in pregnant and non-pregnant women infected with HIV in the Women and Infants Transmission Study
29. Tuberculin skin testing in pregnancy: Trends in a population
30. Control and prevention of tuberculosis in the United Kingdom: Code of practice 2000
31. Chemotherapy and management of tuberculosis: Recommendations 1998
32. Clinical trial of six-month and four-month chemotherapy in the treatment of pulmonary tuberculosis. The results up to 30 months
33. Clinical controlled trial of four short course regimens of chemotherapy (three six-month and one eight-month) for pulmonary tuberculosis
34. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond
35. Chemotherapy of tuberculosis
36. Placental transfer of isonicotinic acid hydrazide
37. A comparison of the in vitro embryotoxicity of three lathyrogens, beta-apn, semicarbazide and isoniazid
38. Nonteratogenicity of isoniazid in mice
39. Transplacental, biological and metabolic effects of isoniazid (INH) in Swiss mice
40. The search for teratogenic activity of some tuberculostatic drugs
41. The inhibition of protein-lysine 6-oxidase by various lathyrogens: Evidence for two different mechanisms
42. Neuroembryopathic effect of INH on the cerebellum of chick embryo
43. Childhood cancer and drugs in pregnancy
44. Isoniazid therapy in relation to later occurrence of cancer in adults and in infants
45. Metabolism and kinetics: Pharmacokinetics of the antibiotic rifampin
46. Observations on laboratory rodents treated with 'Rifamide' during pregnancy
47. Rifampicin: A review
48. Influence d'un antibiotique, las rifampicine, sur le development prenatal de ronguers
49. Rifampicin in pregnancy
50. The maternal and fetal effects of tuberculosis therapy
51. Ethambutol in pregnancy: Observations on embryogenesis
52. Streptomycin: Absorption, diffusion, excretion and toxicity
53. Transmission of streptomycin from maternal blood to the fetal circulation and amniotic fluid
54. The toxic effects of streptomycin and dihydrostreptomycin in pregnancy, illustrated experimentally
55. Streptomycin ototoxicity in the unborn child
56. Zur frage der interuteruinen streptomycin schadigung
57. Existe-t-il une srdete congenitale axquise due a la strepomycine?
58. Hearing loss in infants of tuberculous mothers treated with streptomycin during pregnancy
59. Streptomycin and dihydrostreptomycin medication during pregnancy and their effects on the child's inner ear
60. Streptomycin in pregnancy: Effect on the fetal ear
61. Tuberculosis management in Europe
62. Study of teratogenic activity of trifluoperazine, amitriptyline, ethionamide and thalidomide in pregnant rabbits and mice
63. Effects of hydroxymethylpyrimidine on isoniazid and ethionamide induced teratosis
64. Influence of ethionamide on development of human fetus
65. Ethionamide treatment and pregnancy
66. Course and outcome of pregnancy in women with pulmonary tuberculosis
67. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis
68. Pregnancy and tuberculosis: Influence of treatment on perinatal outcome
69. Obstetrical outcomes among women with extra-pulmonary tuberculosis
70. A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: The emergence of tuberculosis as a major non-obstetric cause of maternal death
71. The early bactericidal activity of drugs in patients with pulmonary tuberculosis
72. Transmission of tubercle bacilli: The effects of chemotherapy
73. The role of BCG vaccine in the prevention and control of tuberculosis in the United States: A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunisation Practices
74. Epidemiology of tuberculosis in the United States, 1985 through 1992
75. Ueber die angeborene tuberkuloese infektion
76. The mechanism of acquired sensitivity
77. Lymphocyte reactivity to antigen in pregnancy
78. Brief report: Congenital tuberculosis
79. Tuberculosis: An old disease but a new threat to the mother, fetus and neonate
80. Congenital tuberculosis: Critical reappraisal of clinical findings and diagnostic procedures
81. Neonatal tuberculosis with pulmonary cavitation
82. Acid fast staining of urine and gastric contents is an excellent indication of mycobacterial disease
83. Congenital tuberculosis
84. Congenital miliary tuberculosis proven by open lung biopsy specimen and successfully treated
85. Nursery exposure of 528 newborns to a nurse with pulmonary tuberculosis
86. Miliary tuberculosis in two infants after nursery exposure. Epidemiologic, clinical and laboratory findings
87. Tuberculosis in the newborn, an emerging disease
88. Antituberculosis drugs and breastfeeding
89. Milk/plasma ratios and contraindicated drugs
90. The transfer of drugs and other chemicals into human milk